Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

Similar articles for PubMed (Select 21702899)

1.
2.

Comparison of drug-eluting stent with bare metal stent for distal de novo unprotected left main coronary artery stenosis. A propensity score-matched cohort study.

Hsueh SK, Wu CJ, Fang HY, Hsieh YK, Fang CY, Chen CJ, Chen SM, Yang CH, Yip HK, Chen MC, Fu M, Cheng CI.

Circ J. 2011;75(2):290-8. Epub 2010 Dec 10.

3.

Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry.

Garg P, Normand SL, Silbaugh TS, Wolf RE, Zelevinsky K, Lovett A, Varma MR, Zhou Z, Mauri L.

Circulation. 2008 Nov 25;118(22):2277-85, 7p following 2285. doi: 10.1161/CIRCULATIONAHA.108.820159. Epub 2008 Nov 10.

4.

In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.

Tolerico PH, Cohen DJ, Kleiman NS, Berger PB, Brilakis ES, Piana RN, Shammo S, Keyes MJ, Kennedy KF, Massaro JM, Saucedo JF; EVENT Investigators.

Catheter Cardiovasc Interv. 2012 Dec 1;80(7):1127-36. doi: 10.1002/ccd.24352. Epub 2012 May 4.

PMID:
22431166
5.

Primary percutaneous coronary intervention for acute myocardial infarction: long-term outcome after bare metal and drug-eluting stent implantation.

Kukreja N, Onuma Y, Garcia-Garcia H, Daemen J, van Domburg R, Serruys PW.

Circ Cardiovasc Interv. 2008 Oct;1(2):103-10. doi: 10.1161/CIRCINTERVENTIONS.108.787762. Epub 2008 Sep 3.

6.

Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention.

Roy P, Buch AN, Javaid A, Okabe T, Raya V, Pinto Slottow TL, Steinberg DH, Smith K, Xue Z, Gevorkian N, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R.

Am J Cardiol. 2008 Feb 1;101(3):293-9. doi: 10.1016/j.amjcard.2007.08.048. Epub 2007 Dec 21.

PMID:
18237587
7.

Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.

Bangalore S, Kumar S, Fusaro M, Amoroso N, Attubato MJ, Feit F, Bhatt DL, Slater J.

Circulation. 2012 Jun 12;125(23):2873-91. doi: 10.1161/CIRCULATIONAHA.112.097014. Epub 2012 May 14.

8.

Borderline trend towards long-term mortality benefit from drug eluting stents implantation in ST-elevation myocardial infarction patients in Poland-data from NRDES registry.

Siudak Z, Dziewierz A, Rakowski T, Żmudka K, Legutko J, Bartuś S, Dragan J, Zasada W, Tokarek T, Kułaga T, Partyka Ł, Dudek D.

Catheter Cardiovasc Interv. 2014 Feb 15;83(3):436-42. doi: 10.1002/ccd.25169. Epub 2013 Sep 23.

PMID:
24038740
9.

Short and long term outcome of percutaneous coronary intervention with drug eluting stent and bare metal stent in patients with chronic kidney disease.

Resmini C, Di Cuia M, Ballocca F, D'Ascenzo F, Bollati M, Moretti C, Omedè PL, Sciuto F, Gaita F, Sheiban I.

Minerva Cardioangiol. 2012 Dec;60(6):573-80.

PMID:
23147435
11.

A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.

Stella PR, Belkacemi A, Dubois C, Nathoe H, Dens J, Naber C, Adriaenssens T, van Belle E, Doevendans P, Agostoni P.

Catheter Cardiovasc Interv. 2012 Dec 1;80(7):1138-46. doi: 10.1002/ccd.23499. Epub 2012 Mar 15.

PMID:
22422607
12.

Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS.

Capodanno D, Di Salvo ME, Capranzano P, Seminara D, Caggegi A, Barrano G, Tamburino C.

Minerva Cardioangiol. 2009 Feb;57(1):1-6.

PMID:
19202514
13.

Comparison of long-term clinical and angiographic outcomes following implantation of bare metal stents and drug-eluting stents in aorto-ostial lesions.

Al-Lamee R, Ielasi A, Latib A, Godino C, Mussardo M, Arioli F, Figin F, Piraino D, Carlino M, Montorfano M, Chieffo A, Colombo A.

Am J Cardiol. 2011 Oct 15;108(8):1055-60. doi: 10.1016/j.amjcard.2011.06.004. Epub 2011 Jul 24.

PMID:
21791332
14.
15.

Clinical outcomes of dialysis patients after implantation of DES: meta analysis and systematic review of literature.

Athappan G, Ponniah T.

Minerva Cardioangiol. 2009 Jun;57(3):291-7. Review.

PMID:
19513010
16.

Long term clinical outcomes of brachytherapy, bare-metal stenting, and drug-eluting stenting for de novo and in-stent restenosis lesions: five year follow-up.

Dogdu O, Yarlioglues M, Kaya MG, Tulumen E, Sarli B, Gunebakmaz O, Ardic I, Kalay N, Akpek M, Kelesoglu S, Basar E.

Cardiol J. 2011;18(6):654-61.

17.
18.

The risk of definitive stent thrombosis is increased after "off-label" stent implantation irrespective of drug-eluting stent or bare-metal stent use.

Hoffmann R, Klinker H, Adamu U, Kelm M, Blindt R.

Clin Res Cardiol. 2009 Sep;98(9):549-54. doi: 10.1007/s00392-009-0039-8. Epub 2009 Aug 11.

PMID:
19669824
19.

Clinical outcomes following drug-eluting versus bare metal stent implantation for lesion subsets excluded from pivotal clinical trials: findings from the GHOST Study (Guthrie Health System Off-Label StenT Study).

Harjai KJ, Orshaw P, Shenoy C, Acharji S, Sporn D, Aboufares A, Stapleton D.

J Interv Cardiol. 2008 Aug;21(4):315-24. doi: 10.1111/j.1540-8183.2008.00380.x. Erratum in: J Interv Cardiol. 2008 Oct;21(5):441.

PMID:
18754967
20.

Long-term clinical outcomes of drug-eluting stents vs bare-metal stents in Chinese patients.

Ho HH, Pong V, Siu CW, Jim MH, Miu R, Yiu KH, Ko R, Tse HF, Kwok OH, Chow WH.

Clin Cardiol. 2010 Jun;33(6):E22-9. doi: 10.1002/clc.20655.

PMID:
20556818
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk